The authors reply
- PMID: 35191880
- DOI: 10.1097/CCM.0000000000005405
The authors reply
Conflict of interest statement
Dr. van den Boogaard’s institution received funding and support for article research from ZonMw. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Comment on
-
Association Between Incident Delirium Treatment With Haloperidol and Mortality in Critically Ill Adults.Crit Care Med. 2021 Aug 1;49(8):1303-1311. doi: 10.1097/CCM.0000000000004976. Crit Care Med. 2021. PMID: 33861548 Free PMC article.
-
Concerns With Association Between Incident Delirium Treatment With Haloperidol and Mortality in Critically Ill Adults.Crit Care Med. 2022 Mar 1;50(3):e322-e323. doi: 10.1097/CCM.0000000000005358. Crit Care Med. 2022. PMID: 35191879 No abstract available.
References
-
- Yoshihiro S, Taito S: Concerns With Association Between Incident Delirium Treatment With Haloperidol and Mortality in Critically Ill Adults. Crit Care Med. 2022; 50:e322–e323
-
- Duprey MS, Devlin JW, van der Hoeven JG, et al.: Association between incident delirium treatment with haloperidol and mortality in critically ill adults. Crit Care Med. 2021; 49:1303–1311
-
- van den Boogaard M, Slooter AJC, Brüggemann RJM, et al.; REDUCE Study Investigators: Effect of haloperidol on survival among critically ill adults with a high risk of delirium: The REDUCE randomized clinical trial. JAMA. 2018; 319:680–690
-
- Milbrandt EB, Kersten A, Kong L, et al.: Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med. 2005; 33:226–229; discussion 263–265
-
- Rood PJT, van de Schoor F, van Tertholen K, et al.: Differences in 90-day mortality of delirium subtypes in the intensive care unit: A retrospective cohort study. J Crit Care. 2019; 53:120–124
Publication types
LinkOut - more resources
Full Text Sources